Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Damian Karas maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $168 to $175.
Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $175 to $178.
RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $169 to $176.
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and raises the price target from $165 to $172.
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...
Xylem Inc. (NYSE: XYL) reported Q3 2025 results beating Wall Street estimates with $1.37 EPS and $2.27B in revenue.
Xylem (NYSE:XYL) raises FY2025 Adj EPS guidance from $4.70-$4.85 to $5.03-$5.08 vs $4.84 analyst estimate. Raises FY2025 sales ...
